On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

Listen Live Now » 1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
66° Feels Like: 66°
Wind: WSW 10 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Sunny 66°

Tonight

Clear 46°

Tomorrow

Sunny 73°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

FDA approves labels with lower doses for zolpidem sleep drugs

The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed

(Reuters) - The Food and Drug Administration approved label changes incorporating lower dosages for sleep medications containing zolpidem, a drug that can continue to affect patients' mental alertness even a day after its use.

The regulator approved changes to the labels of Sanofi SA's Ambien, Ambien CR and Meda AB's Edluar on Tuesday.

The agency said patients who take zolpidem extended-release drugs, such as Ambien CR, should not drive or take part in activities that require complete mental alertness the next day.

The FDA in January asked zolpidem manufacturers, including NovaDel Pharma Inc and Swedish drugmaker Meda, to reduce recommended dosages on the drugs' labels.

The regulator also said that women were more susceptible to the risk as they eliminated the drug from the blood more slowly than men.

The FDA recommended doses of 5 mg for women and either 5 mg or 10 mg for men for immediate-release zolpidem products such as Sanofi's Ambien.

The initial dose of extended-release products is 6.25 mg for women and either 6.25 or 12.5 mg for men, according to the FDA.

(Reporting By Vrinda Manocha in Bangalore; Editing by Sreejiraj Eluvangal)

Comments